SHINE Medical Technologies, Inc.
High-specific activity Iodine-131 medical isotope produced via aqueous homogeneous nuclear fission technology
- Sector
- Medtech
- Headquarters
- JANESVILLE, WI
- Founded
- 2010
- Latest Form D
- $18.1M, Jun 2019
- Total capital
- $55.9M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $55.9M
- 5 Form D · last Jun 2019
- 88 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 3 pending · first 2022
- Rank in peer group#8 of 29
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$18.1M
- Private capital raisedForm D · SEC · 4th filing$18M
- Private capital raisedForm D · SEC · 3rd filing$6.9M
- Private capital raisedForm D · SEC · 2nd filing$11.5M
- Private capital raisedForm D · SEC · 1st filing$1.4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 29 peers
Line = medianMedtech · Molecule
- Federal grants#4 · top 14%
- Granted patents#8 · top 28%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Gregory Richard PieferResearcherExecutive Officer, Director, PromoterLinked by 1 patent
- Anton M. AsmuthExecutive Officer, DirectorNamed in SEC Form D filings
- Brad M. WucherpfennigDirectorNamed in SEC Form D filings
- Christopher H. ManueleDirectorNamed in SEC Form D filings
- Darin Richard JanecekExecutive OfficerNamed in SEC Form D filings
- David A. WeissburgExecutive Officer, Director, PromoterNamed in SEC Form D filings
Show all 21 people
- Donald H. WhelleyDirectorNamed in SEC Form D filings
- Fred H. MancheskiDirectorNamed in SEC Form D filings
- Gordon M. GunnlaugssonDirectorNamed in SEC Form D filings
- Gregory M. SmithDirectorNamed in SEC Form D filings
- Harsh M. SinghExecutive OfficerNamed in SEC Form D filings
- James M. CostedioExecutive OfficerNamed in SEC Form D filings
- Katrina M. PitasExecutive OfficerNamed in SEC Form D filings
- Philip M. HalpernDirectorNamed in SEC Form D filings
- Richard Vann BynumExecutive Officer, DirectorNamed in SEC Form D filings
- Richard H. LeazerDirectorNamed in SEC Form D filings
- Richard Richard Vann BynumExecutive OfficerNamed in SEC Form D filings
- Stephen Clermont HathawayExecutive Officer, PromoterNamed in SEC Form D filings
- Steve M. MiltenbergerExecutive OfficerNamed in SEC Form D filings
- Thomas Rockwell MackieDirectorNamed in SEC Form D filings
- Todd M. AsmuthExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 5- GrantedAqueous Assembly And Control MethodUSPTOUS 11,361,873
- GrantedApparatus and Method for Generating Medical IsotopesUSPTOUS 11,238,999
- PendingIon Source And Neutron GeneratorUSPTOApplication 62836481
Show all 5 patent records
- Aqueous Assembly And Control MethodJun 14, 2022 · US 11,361,873Granted
- Apparatus and Method for Generating Medical IsotopesFeb 1, 2022 · US 11,238,999Granted
- Ion Source And Neutron GeneratorApplication 62836481Pending
- Aqueous Assembly And Control MethodApplication PCTUS2013031837Pending
- Segmented Reaction Chamber For Radioisotope ProductionApplication PCTUS2011023024Pending
Related companies, and why
- SHINE TECHNOLOGIES, LLCShares a founder: Jeff Driscoll
- ParaNano Wound Care, LLCSimilar federal contract value in Medtech · null in contracts
- PROMEDIX, INC.Similar federal contract value in Medtech · null in contracts
- SAFETYSPECT, INC.Similar federal contract value in Medtech · null in contracts
- DIASCOPIC, LLCSimilar federal contract value in Medtech · null in contracts
- IQ MEDICAL IMAGING LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .